{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:39:27Z","timestamp":1776872367366,"version":"3.51.2"},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF\u20102022R1A2C2006607"],"award-info":[{"award-number":["NRF\u20102022R1A2C2006607"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Experimental Dermatology"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Chronic spontaneous urticaria (CSU) remains challenging to manage in patients who do not respond adequately to antihistamines or currently available immunomodulatory therapies. Intramuscular injection of autologous total IgG (autologous immunoglobulin therapy: AIGT) has demonstrated clinical efficacy, safety and immunomodulatory effects in patients with moderate\u2010to\u2010severe atopic dermatitis in a randomized placebo\u2010controlled clinical trial. However, the clinical usefulness of AIGT in patients with CSU has not been evaluated. We conducted a prospective open\u2010label pilot study to assess the efficacy and safety of AIGT in antihistamine\u2010refractory CSU. Fifteen adults with CSU received nine weekly intramuscular injections of 100\u2009mg autologous IgG from Week 0 through Week 8 (inclusive). The primary outcome was the change in Urticaria Activity Score over 7\u2009days (UAS7) at Week 12 from baseline. Secondary outcomes included the Urticaria Control Test (UCT), chronic urticaria\u2010specific quality of life (CU\u2010QoL) scores and patient\u2010reported disease burden using a visual analogue scale (VAS). The median change in UAS7 at Week 12 from baseline was \u221213.0 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Significant improvements in UCT, CU\u2010QoL and VAS were also observed at Week 12 from baseline (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). In longitudinal analyses, improvements in symptom burden and quality of life were detectable from Week 4 and were maintained through Week 24. Serum total IgG increased by a median of +68.0\u2009mg\/dL from baseline to Week 12 (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). No serious adverse events occurred. In conclusion, AIGT improved disease activity, urticaria control, quality of life and patient\u2010reported burden in patients with antihistamine\u2010refractory CSU. Further studies are needed to evaluate the clinical usefulness of AIGT in CSU.\n                  <\/jats:p>","DOI":"10.1111\/exd.70249","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:41:53Z","timestamp":1776073313000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Efficacy and Safety of Intramuscular Injections of Autologous Total\n                    <scp>IgG<\/scp>\n                    in Patients With Chronic Spontaneous Urticaria: An Open\u2010Label Prospective Pilot Trial"],"prefix":"10.1111","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7517-1715","authenticated-orcid":false,"given":"Young\u2010Min","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Allergy and Clinical Immunology Ajou University School of Medicine  Suwon Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7224-3421","authenticated-orcid":false,"given":"Myung\u2010Eun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology Ajou University School of Medicine  Suwon Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-4759","authenticated-orcid":false,"given":"Byul","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology Ajou University School of Medicine  Suwon Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5253-6577","authenticated-orcid":false,"given":"Dong\u2010Ho","family":"Nahm","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology Ajou University School of Medicine  Suwon Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15090"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2020.12.5.750"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00852-3"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.16243"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.70095"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.15568"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2024.16.6.626"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.04.010"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.10.019"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2024.16.6.567"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103054"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2020.12.6.949"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.135490"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000090656"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2015.27.6.784"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15640"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000458152"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1572863"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02033.x"},{"issue":"7","key":"e_1_2_11_21_1","first-page":"237","article-title":"Low\u2010Dose Intravenous Gammaglobulin in the Treatment of Severe Autoimmune Urticaria","volume":"39","author":"Pereira C.","year":"2007","journal-title":"European Annals of Allergy and Clinical Immunology"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0249"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3401"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029486"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1242860"}],"container-title":["Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/exd.70249","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/exd.70249","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/exd.70249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:43:09Z","timestamp":1776868989000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/exd.70249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/exd.70249"],"URL":"https:\/\/doi.org\/10.1111\/exd.70249","archive":["Portico"],"relation":{},"ISSN":["0906-6705","1600-0625"],"issn-type":[{"value":"0906-6705","type":"print"},{"value":"1600-0625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70249"}}